Comparison of adding magnesium sulfate, dexmedetomidine and ondansetron to lidocaine for gargling before laryngoscopy and endotracheal intubation to prevent sore throat: a randomized clinical trial.
Erfaneh AbedzadehHesameddin ModirShirin PazookiFarzad Zamani BarsariAmir Almasi-HashianiPublished in: Medical gas research (2023)
Postoperative sore throat is one well-recognized complication, occurring most frequently following tracheal intubation. Effective prevention of postoperative sore throat has been recognized as a top priority, bringing pleasant feelings and satisfaction to patients. This study aimed to assess the efficacy of magnesium sulfate, dexmedetomidine and ondansetron gargle with lidocaine administrated prior to laryngoscopy and tracheal intubation for postoperative sore throat prevention alongside hemodynamic management. This double-blind randomized clinical trial enrolled 105 general anesthesia-administered patients who had undergone laryngoscopy and endotracheal intubation, and they were equally randomized into three groups: magnesium sulfate, dexmedetomidine, and ondansetron groups. No significant intergroup difference was seen in oxygen saturation, non-invasive blood pressure, heart rate, duration of surgery, postoperative complications, analgesic consumption, and incidence of cough and hoarseness. The results showed statistically significant intergroup differences in pain scores and average pain intensity in the dexmedetomidine group was significantly lower than the other groups. Results suggest that dexmedetomidine gargle with lidocaine before general anesthesia induction could be recommended as an option depending on the patient's general condition and the anesthesiologist's discretion.
Keyphrases
- heart rate
- double blind
- blood pressure
- cardiac arrest
- cardiac surgery
- placebo controlled
- patients undergoing
- chronic pain
- heart rate variability
- neuropathic pain
- end stage renal disease
- clinical trial
- newly diagnosed
- pain management
- minimally invasive
- chronic kidney disease
- ejection fraction
- phase iii
- risk factors
- acute kidney injury
- chemotherapy induced
- type diabetes
- open label
- case report
- high intensity
- study protocol
- hypertensive patients
- metabolic syndrome
- randomized controlled trial
- adipose tissue
- spinal cord injury
- weight loss
- anti inflammatory
- clinical evaluation